Sort
51,593 grants matching “hepatitis”
Regulation of Cellular Cholesterol Homeostasis
$480,383Peter John Espenshade · Johns Hopkins University · R01 · FY2021 · HL
Molecular Modulation of Virus Capsid Assembly
$480,376Adam Zlotnick · Trustees Of Indiana University · R01 · FY2012 · AI
MODELING OF HOST IMMUNE RESPONSES AND ANTIVIRAL THERAPY AGAINST HEPATITIS C
$480,307Harel Dahari · University Of New Mexico · P20 · FY2011 · RR
Evaluating the impact of genetic ancestry and HIV on cirrhosis progression and response to statin therapy among a diverse multi-ethnic cohort of patients with cirrhosis
$480,289David Seth Goldberg · University Of Miami School Of Medicine · U01 · FY2023 · DK
Relationship between maternal and fetal immune responses
$480,211Adriana Weinberg · University Of Colorado Denver · R01 · FY2023 · HD
Evaluation of a Hepatitis B Outreach Intervention for Cambodians
$480,206Victoria M Taylor · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Cross platform analysis of drug targets and toxicity of bath salts
$480,135Isaac T Schiefer · University Of Toledo Health Sci Campus · U01 · FY2022 · DA
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$480,113David L Thomas · Johns Hopkins University · R01 · FY2006 · DA
Lipid Aldehyde and Ethanol Induced Liver Damage
$480,084Dennis Petersen · University Of Colorado Denver · R37 · FY2016 · AA
Biologic Studies with Peroxisome Proliferators and PPARs
$480,053Janardan K. Reddy · Northwestern University At Chicago · R01 · FY2006 · GM
NASH PROJECT
$480,051Case Western Reserve University · U01 · FY2004 · DK
Biologic Studies with Peroxisome Proliferators and PPARs
$480,031Janardan K. Reddy · Northwestern University At Chicago · R01 · FY2007 · GM
Genes Related to HCC Progression in LD and DD Transplant
$480,030Robert A Fisher · Virginia Commonwealth University · R01 · FY2010 · DK
Biologic Studies with Peroxisome Proliferators and PPARs
$480,009Janardan K. Reddy · Northwestern University At Chicago · R01 · FY2008 · GM
Continuation of ChiLDReN, the Childhood Liver Disease Research Network: Indiana University
$480,001Jean Pappas Molleston · Indiana University Indianapolis · U01 · FY2022 · DK
Simultaneous Determination of Free, Total, and Normalized Concentrations of Bioactive Compounds
$480,000Florin Marcel Musteata · Albany College Of Pharmacy · R15 · FY2018 · GM
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases
$480,000Debanjan Dhar · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · DK
Continuation of ChiLDReN, the Childhood Liver Disease Research Network: Indiana University
$480,000Jean Pappas Molleston · Indiana University Indianapolis · U01 · FY2023 · DK
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
$479,998David E Cohen · Brigham And Women'S Hospital · R01 · FY2024 · DK
Regulation of polycystin-2 channel activity
$479,952Titus Jonathon Boggon · Yale University · R01 · FY2010 · DK
Transcriptional and non-transcriptional functions of IRF3 in ALD
$479,934Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AA
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
$479,923Mikhail Nikiforov · Duke University · R01 · FY2024 · CA
Diabetes, glucose metabolism, and neuroplasticity in the vagal complex
$479,837Bret N Smith · Colorado State University · R01 · FY2022 · DK
TTC39B in Metabolism
$479,823Alan Richard Tall · Columbia University Health Sciences · R01 · FY2020 · HL
Ferristatin: A New Small Molecule Inhibitor of Iron Transport
$479,807Marianne Wessling-Resnick · Harvard School Of Public Health · RC1 · FY2009 · DK